SAR 88.2
(-0.34%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 986.81 Million SAR | 27.83% |
2022 | 861.81 Million SAR | 9.22% |
2021 | 787.44 Million SAR | 7.99% |
2020 | 735.09 Million SAR | 17.86% |
2019 | 623.71 Million SAR | 19.53% |
2018 | 521.17 Million SAR | 10.28% |
2017 | 463.08 Million SAR | 26.26% |
2016 | 376.25 Million SAR | 25.3% |
2015 | 289.23 Million SAR | 4.94% |
2014 | 275.55 Million SAR | 4.44% |
2013 | 262.65 Million SAR | 184.27% |
2012 | 230.6 Million SAR | -232.54% |
2011 | 245.55 Million SAR | 26.03% |
2010 | 194.83 Million SAR | 3.71% |
2009 | 187.87 Million SAR | 17.84% |
2008 | 159.42 Million SAR | 25.3% |
2007 | 127.24 Million SAR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 250.89 Million SAR | -2.46% |
2024 Q2 | 249.3 Million SAR | -7.24% |
2024 Q3 | 167.78 Million SAR | -29.44% |
2023 Q4 | 266.97 Million SAR | 10.22% |
2023 FY | - SAR | 27.83% |
2023 Q1 | 252.35 Million SAR | -5.71% |
2023 Q2 | 235.47 Million SAR | -6.69% |
2023 Q3 | 242.2 Million SAR | 2.86% |
2022 Q3 | 195.82 Million SAR | -2.3% |
2022 Q1 | 207.79 Million SAR | 1.2% |
2022 FY | - SAR | 9.22% |
2022 Q2 | 200.43 Million SAR | -3.54% |
2022 Q4 | 267.63 Million SAR | 36.67% |
2021 Q4 | 205.33 Million SAR | 4.36% |
2021 Q3 | 196.75 Million SAR | 0.2% |
2021 Q2 | 196.36 Million SAR | -1.54% |
2021 FY | - SAR | 7.99% |
2021 Q1 | 199.42 Million SAR | 4.59% |
2020 Q2 | 170.99 Million SAR | 4.95% |
2020 Q1 | 162.93 Million SAR | -10.91% |
2020 Q3 | 214.65 Million SAR | 25.53% |
2020 Q4 | 190.67 Million SAR | -11.17% |
2020 FY | - SAR | 17.86% |
2019 Q4 | 182.89 Million SAR | 28.46% |
2019 FY | - SAR | 19.53% |
2019 Q1 | 160.1 Million SAR | 17.44% |
2019 Q2 | 141.94 Million SAR | -11.34% |
2019 Q3 | 142.38 Million SAR | 0.3% |
2018 FY | - SAR | 10.28% |
2018 Q4 | 136.33 Million SAR | 47.26% |
2018 Q2 | 101.01 Million SAR | -13.07% |
2018 Q1 | 116.2 Million SAR | -13.04% |
2018 Q3 | 92.58 Million SAR | -8.34% |
2017 Q1 | 118.85 Million SAR | 10.88% |
2017 Q2 | 110.6 Million SAR | -6.94% |
2017 Q3 | 112.91 Million SAR | 2.09% |
2017 FY | - SAR | 26.26% |
2017 Q4 | 133.62 Million SAR | 18.34% |
2016 Q2 | 92.12 Million SAR | -7.57% |
2016 Q3 | 79.32 Million SAR | -13.89% |
2016 Q1 | 99.66 Million SAR | 24.36% |
2016 FY | - SAR | 25.3% |
2016 Q4 | 107.19 Million SAR | 35.13% |
2015 FY | - SAR | 4.94% |
2015 Q2 | 78.71 Million SAR | 2.15% |
2015 Q1 | 77.06 Million SAR | 12.57% |
2015 Q4 | 80.14 Million SAR | 23.3% |
2015 Q3 | 64.99 Million SAR | -17.43% |
2014 Q4 | 68.45 Million SAR | -22.17% |
2014 FY | - SAR | 4.44% |
2014 Q1 | 75.5 Million SAR | 8.85% |
2014 Q3 | 87.96 Million SAR | 15.37% |
2014 Q2 | 76.24 Million SAR | 0.97% |
2013 Q3 | 62.46 Million SAR | -13.67% |
2013 Q4 | 69.36 Million SAR | 11.06% |
2013 FY | - SAR | 184.27% |
2013 Q2 | 72.34 Million SAR | 3.34% |
2013 Q1 | 70.01 Million SAR | 114.25% |
2012 Q1 | 60.08 Million SAR | 0.0% |
2012 Q2 | 58.4 Million SAR | -2.79% |
2012 FY | - SAR | -232.54% |
2012 Q3 | 47.47 Million SAR | -18.72% |
2012 Q4 | -491.43 Million SAR | -1135.12% |
2011 FY | - SAR | 26.03% |
2010 FY | - SAR | 3.71% |
2009 FY | - SAR | 17.84% |
2008 FY | - SAR | 25.3% |
2007 FY | - SAR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Dallah Healthcare Company | 631.92 Million SAR | -56.159% |
National Medical Care Company | 323.02 Million SAR | -205.495% |
Al Hammadi Company For Development and Investment | 438.27 Million SAR | -125.156% |
Middle East Healthcare Company | 551.23 Million SAR | -79.018% |
Dr. Sulaiman Al Habib Medical Services Group Company | 2.54 Billion SAR | 61.216% |
Canadian General Medical Center Complex Company | 19.92 Million SAR | -4853.018% |
Arabian International Healthcare Holding Company | 111.1 Million SAR | -788.169% |
Future Care Trading Co. | 15.6 Million SAR | -6222.441% |
Naba Alsaha Medical Services Company | 65.27 Million SAR | -1411.68% |
Lana Medical Co. | 4.56 Million SAR | -21505.47% |
Al-Modawat Specialized Medical Co. | 20.76 Million SAR | -4651.494% |